Danaher acquires GE biopharma for $21.4 billion
General Electric is selling its biopharma business for $21.4 billion, with shares in the company jumping 16 percent upon the news...
List view / Grid view
News
European Medicines Agency forced to pay London lease
The European Medicines Agency (EMA) has lost a High Court case, meaning it will have to pay the remaining 20 years left on the lease...
Blockchain could help ensure clinical trial integrity
US researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data using blockchain...
Utilising electric car batteries for safer and cheaper medicine manufacture
A method commonly used in lithium-ion batteries has been developed to help the safer and cheaper manufacture of medicines...
EU measures in support of generic pharmaceuticals producers
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
‘Smart drug’ shows promise for metastatic triple-negative breast cancer
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
Sales of generic oncology drugs surge
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
Structural barriers biggest reason for low participation in clinical trials
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
Inadequate FDA oversight concerning fentanyl prescriptions
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
Oral antifungals used to treat yeast infections could lead to miscarriage
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
Drug combination may become new standard treatment for advanced kidney cancer
Immunotherapy drug plus targeted agent provided better progression-free survival and shrank tumors in more patients than standard one-drug treatment...
Perigord announces the release of GLAMS CMO
Simplify your artwork process, get closer to your customers and strengthen compliance...
Biotech firm awarded for approach to drug development
A UK based biotech firm has been awarded a grant to develop a treatment for osteoarthritis, after promising results from a Phase I trial...
Policy to improve access and foster price competition for generics
A policy has been implemented to aid companies in the formulation, production and manufacture of generic drugs, especially when the originals are expensive...
Phase III combination trial improves survival in men with metastatic prostate cancer
A Phase III clinical trial has shown that metastatic prostate cancer improved through the use of a combination therapy with enzalutamide...
